Ottobock stock: Goldman cuts target to EUR 75, little changed pre-market
Published on 10/23/2026 at 08:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCompany news and market context
- On October 21, 2026, Goldman Sachs lowered Ottobock's target to EUR 75 while retaining its Buy rating.
- Ottobock lists its Q3 2026 quarterly communication for November 12, 2026.
- Ottobock stock trades pre-market at EUR 50.03 at 8:54 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.06 percent above the Xetra close of October 22, 2026.
On October 21, 2026, Goldman Sachs cut its Ottobock price target from EUR 88.00 to EUR 75.00 while retaining its Buy rating, according to MarketScreener. Ottobock stock trades pre-market at EUR 50.03 at 8:54 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.06 percent above the Xetra close of October 22, 2026 (EUR 50.00).
Analyst target update
Goldman analyst Richard Felton cited expectations for weak third-quarter revenue growth and continued weakness in North America. The bank retained its Buy rating while lowering its target from EUR 88.00 to EUR 75.00; the quarterly report is scheduled for November 12, 2026, MarketScreener reported.
Ahead of the Xetra open
The indication is EUR 0.03 above the Xetra close in absolute terms. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Ottobock stock.
Business and today's agenda
Ottobock develops and distributes medical technology products and services in prosthetics, neuro-orthotics and exoskeletons, according to its investor relations site. The company lists its Q3 2026 quarterly communication for November 12, 2026, on the same calendar. Market context: Market report DAX.
